| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.9M | +358.0% |
| Cost of Revenue | $5.3M | +389.1% |
| Gross Profit | $13.7M | +347.0% |
| R&D Expense | $2.6M | +54.1% |
| SG&A Expense | $33.0M | +45.0% |
| Operating Income | -$21.9M | -2.6% |
| Interest Expense | $1K | -83.5% |
| Pre-tax Income | -$19.4M | +6.4% |
| Income Tax | -$2.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.4M | -85.9% |
| Accounts Receivable | $596K | +89.2% |
| Inventory | $2.7M | -3.6% |
| Current Assets | $123.5M | -38.4% |
| Total Assets | $279.6M | -0.3% |
| Current Liabilities | $7.8M | +80.0% |
| Total Liabilities | $12.2M | +28.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.7M | +18.2% |
| Capital Expenditures | $787K | +434.9% |
| Investing Cash Flow | -$155.9M | -116.7% |
| Financing Cash Flow | $8K | -100.0% |
| Free Cash Flow | -$12.5M | +13.6% |
| -1.4% |
| Net Income | -$17.0M | +7.4% |
| Stockholders' Equity |
| $267.4M |
| -1.3% |